Cargando…

Measles Seroprevalence and Vaccine Responses in HIV-Positive Patients

Detalles Bibliográficos
Autores principales:	Bieńkowski, Carlo, Siwak, Ewa, Kowalska, Justyna D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598919/ https://www.ncbi.nlm.nih.gov/pubmed/34805435 http://dx.doi.org/10.1093/ofid/ofab505

Ejemplares similares

The Clinical Effectiveness and Safety of Vaccinations against COVID-19 in HIV-Positive Patients: Data from Observational Study in Poland
por: Bieńkowski, Carlo, et al.
Publicado: (2023)

Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients
por: Kowalska, Justyna D., et al.
Publicado: (2016)

HIV‐positive patients diagnosed with COVID‐19 in Central and Eastern European Countries
por: Skrzat‐Klapaczyńska, Agata, et al.
Publicado: (2022)

Mass Measles Vaccination
por: Ghorbani, Gholam Ali
Publicado: (2012)

Seroprevalence of measles vaccine antibody response in vertically HIV-infected children, in Morocco
por: Haban, Houda, et al.
Publicado: (2018)

Prevalence of measles in vaccinated and non-vaccinated children
por: Zahoor, Muhammad Asif, et al.
Publicado: (2015)

Measles Vaccination Coverage and Cases among Vaccinated Persons
por: Althaus, Christian L., et al.
Publicado: (2015)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Incentivized self-vaccination for global measles eradication
por: Sievers, Benjamin L., et al.
Publicado: (2022)

Hantavirus infection in HIV positive individuals in Rio de Janeiro, Brazil: a seroprevalence study
por: da Cruz Lamas, Cristiane, et al.
Publicado: (2013)

Measles-associated pneumonia in an immunocompromised patient: Persistent shortcomings in vaccination guidelines
por: Portais, A., et al.
Publicado: (2021)

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
por: Özdemir, Öner
Publicado: (2020)

MR/MMR Vaccine in Measles Control: A Case of Missed Opportunity?
por: Sharma, Karun D, et al.
Publicado: (2014)

Testing for HIV Increases the Odds of Correct Fetal Ultrasound Result
por: Bieńkowski, Carlo, et al.
Publicado: (2022)

Acute Encephalopathy Following Measles Vaccination: A Novel Entity
por: Kasinathan, Ananthanarayanan, et al.
Publicado: (2021)

Partial third nerve palsy after Measles Mumps Rubella vaccination
por: Manzotti, Francesca, et al.
Publicado: (2010)

Buschke–Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine
por: Deshmukh, Ashish, et al.
Publicado: (2022)

Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland
por: Kowalska, Justyna D., et al.
Publicado: (2022)

Acute pancreatitis as a clinical presentation of COVID-19 in a patient with HIV infection: a case report
por: Kowalska, Justyna D, et al.
Publicado: (2022)

Is the HIV Seroprevalence among Iraqi Patients with β-thalassemia Major Underestimated or not Prevalent?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2021)

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients
por: ABDI, Basma, et al.
Publicado: (2022)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Decreased vaccination coverage and recurrence risk of measles due to COVID-19 pandemic
por: Mazidimoradi, Afrooz, et al.
Publicado: (2021)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Measles and Secondary Hemophagocytic Lymphohistiocytosis
por: Iaria, Chiara, et al.
Publicado: (2012)

Seroprevalence of Hepatitis B and Hepatitis C virus infection among HIV infected patients in Mumbai
por: Sawant, Sandhya, et al.
Publicado: (2010)

Seroprevalence of Hepatitis B and C in HIV Seropositive and Chronic Renal Failure Patients in North India
por: Singh, Mini P, et al.
Publicado: (2011)

Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
por: Sapuła, Mariusz, et al.
Publicado: (2022)

Decreasing Seroprevalence of Measles Antibodies after Vaccination – Possible Gap in Measles Protection in Adults in the Czech Republic
por: Smetana, Jan, et al.
Publicado: (2017)

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022)

The Prevention of Measles
Publicado: (1898)

Measles in India: Challenges & recent developments
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2015)

Seroprevalence of IgG antibodies against measles in a selected Polish population – do we need to be re-vaccinated?
por: HOLKA, JUSTYNA, et al.
Publicado: (2020)

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
por: Whitaker, Heather J, et al.
Publicado: (2021)

Seroprevalence of HIV Among Intravenous Drug Users in Amritsar: Risk Factors and Risk Behavior
por: Arora, Usha
Publicado: (2009)

Seroprevalence of Syphilis among a Cohort of HIV-infected Subjects in North Central Nigeria
por: Forbi, Joseph, et al.
Publicado: (2009)

Seroprevalence of HIV among blood donors in a teaching hospital at Kolar, South India
por: Das, Subhashish, et al.
Publicado: (2013)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

Measles lessons in an anti-vaccination era: public health is a social duty, not a political option
por: Lancella, L., et al.
Publicado: (2017)

Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response)
por: Anzinger, Joshua J.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ebfkrcdn45us6c5um52rbf5s8n